Aroclor 1254

CASRN 11097-69-1

  • IRIS Summary (PDF) (26 pp, 167 K)
  • Status: Aroclor 1254 is not being reassessed by IRIS at this time.

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (26 pp, 167 K) last updated: 10/01/1994

RfD (mg/kg-day) System Basis PoD Composite UF Confidence
2 x10-5 Immune, Dermal, Ocular Ocular exudate, inflamed and prominent Meibomian glands, distorted growth of finger and toe nails; decreased antibody (IgG and IgM) response to sheep erythrocytes LOAEL : 5 x10-3
mg/kg-day
300 Medium

Reference Concentration for Inhalation Exposure (RfC) (PDF) (26 pp, 167 K)
Not assessed under the IRIS Program.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (26 pp, 167 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (26 pp, 167 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (26 pp, 167 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.